Christopher Timmermann

Co-director of the UCL Centre for Consciousness Research

Data updated

Papers

54 publications

Trials

0 clinical trials

Research Footprint

Christopher Timmermann appears in 54 tracked papers (2018–2026), most studied alongside DMT, Psilocybin and LSD, across Neuroimaging & Brain Measures, Depressive Disorders and Healthy Volunteers.

Most-cited paper: Increased global integration in the brain after psilocybin therapy for depression (425 citations).

Frequent co-authors: Robin Carhart-Harris, David Nutt and Leor Roseman.

Background & Research

Christopher Timmermann is a neuroscientist and psychologist focusing on the mechanisms of psychedelics on the brain and mind. Having led the DMT Research Group at Imperial College London, he now co-directs the UCL Centre for Consciousness Research. His work uses EEG and fMRI to map the 'DMT state' and explores the intersection of psychedelics, meditation, and human consciousness.

Key Impact

Leading the vanguard of research into DMT and its profound effects on human consciousness and neural dynamics.

54

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

88 collaborators· click a node to visit their profile

Full network →

Compounds

DMTPsilocybinLSDPlaceboKetamineAyahuasca5-MeO-DMTMescaline

Topics

Neuroimaging & Brain MeasuresDepressive DisordersHealthy VolunteersAnxiety DisordersMajor Depressive Disorder (MDD)Medicinal Chemistry & Drug DevelopmentSubstance Use Disorders (SUD)Personality & Trait FactorsEquity and EthicsTreatment-Resistant Depression (TRD)Safety & Risk ManagementSet & SettingSchizophreniaPalliative & End-of-Life DistressInterpersonal Functioning & Social ConnectednessEating DisordersNeurocognitive DisordersObsessive-Compulsive Disorder (OCD)PTSDOlder AdultsHealth Economics & ReimbursementMicrodosingTobacco/Nicotine Use Disorder (TUD)Public Health, Prevention & Behaviour Change

Top Collaborators

Affiliations

Institutions, companies, and organisations Christopher Timmermann is associated with.

Imperial College London

academic
Faculty / StaffCurrent

Head, Psychedelics Research Group

The Centre for Psychedelic Research, led by Professor David Nutt and Dr. David Erritzoe, focuses heavily on the action of psychedelic drugs in the brain and their clinical utility as aides to psychotherapy. Thanks to their extensive neuroimaging studies, this group has proposed vital mechanisms for how psychedelics work, including the Entropic Brain Theory and REBUS (RElaxed Beliefs Under Psychedelics).

View stakeholder →

University College London

academic
Affiliate

The Understanding Neuroplasticity Induced by Tryptamines (UNITY) Project was launched at University College London. UNITY represents the first-in-human study of psychedelics at UCL. The team utilizes techniques such as fMRI, eye-tracking and experience sampling to enhance our understanding of the neurobiological mechanisms predicting cognitive and mental health outcomes following psychedelic use, initially investigating the effects of DMT.

View stakeholder →